Kymera shareholders elect Albers and Baker as Class II directors at 2025 annual meeting

Kymera Therapeutics, Inc.

Jeffrey Albers elected with 55,765,189 votes for, 3,142,251 withheld.
Felix J. Baker elected with 51,745,887 votes for, 7,161,553 withheld.
Advisory say-on-pay resolution approved: 54,364,880 for, 4,531,413 against.
Ernst & Young ratified as independent auditor for FY2025 with 61,644,725 votes for.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.